Find a summary of the most popular posts on excipients and formulation of the last week: Top posts of the week #1 Cyclodextrin complexation studies as the first step for repurposing of chlorpromazine #2 Design (QbD) Approach to Match…

In this contribution, we report the development of original nanocomposite cryogels for sustained topical delivery of hydrophobic natural active substances such as cannabidiol (CBD). The cryogels were fabricated by a method involving…

Find a summary of the most popular posts on excipients and formulation of the last week: Top posts of the week #1 Combating Coronavirus: Key Role of Cyclodextrins in Treatment and Prevention #2 Curcumin-loaded solid self-emulsifying drug…

The therapeutic effect of the Cannabis plant largely depends on the presence and specific ratio of a spectrum of phytocannabinoids. While prescription of medicinal Cannabis for various conditions constantly grows, its consumption is mostly…

Cannabidiol (CBD) is the main cannabinoid naturally occurring in hemp. It has recently attracted the attention of the scientific community because of its numerous pharmacological activities. However, its legal status changes depending on…

Statement from Commissioner of Food and Drugs - Food and Drug Administration Stephen M. Hahn M.D. at March 05, 2020 Over the past year, the U.S. Food and Drug Administration has embarked on a comprehensive evaluation of cannabidiol…

Cannabidiol (CBD) is highly lipophilic, and its oral bioavailability is known to be very low in humans. In this study, we developed a novel nanoemulsion preparation of CBD (CBD-NE) to improve the poor solubility and absorption of CBD. The…

Cannabidiol (CBD) and the potential benefit is the current hot topic. Just found this publication by the group of Elka Touítou Hebrew University of Jerusalem from 2003. She will hold at this years PBP Worldmeeting the presentation:…

The FDA understands that there is increasing interest in the potential utility of cannabis for a variety of medical conditions, as well as research on the potential adverse health effects from use of cannabis. To date, the FDA has not…

Cannabis has been used in pain management since 2900 BC. In the 20th century, synthetic cannabinoids began to emerge, thus opening the way for improved efficacy. The search for new forms of synthetic cannabinoids continues and, as such, the…